ESC Professional Premium Access

Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study

Congress Presentation

About the speaker

Doctor Jakub Gumprecht

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)
0 follower

6 more presentations in this session

External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation

Speaker: Doctor G. Moschovitis (Lugano, CH)


Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients

Speaker: Doctor U. Baumer (Vienna, AT)


Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation

Speaker: Ms A. Lizancos Castro (Vigo, ES)


Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study

Speaker: Mr C. Tsang (Hong Kong, HK)


Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization

Speaker: Mr S. Majumder (Minneapolis, US)


Access the full session

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Speakers: Doctor J. Gumprecht, Doctor G. Moschovitis, Doctor U. Baumer, Ms A. Lizancos Castro, Mr C. Tsang...

About the event


ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by